Fennec Pharmaceuticals Ownership | Who Owns Fennec Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Fennec Pharmaceuticals Ownership Summary


Fennec Pharmaceuticals is owned by 15.86% institutional investors, 16.11% insiders, and 68.03% retail investors. Southpoint capital advisors lp is the largest institutional shareholder, holding 14.90% of FENC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.20% of its assets in Fennec Pharmaceuticals shares.

FENC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockFennec Pharmaceuticals15.86%16.11%68.03%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Southpoint capital advisors lp4.08M14.90%$25.77M
Sonic gp2.41M8.80%$15.21M
Solas capital management2.25M8.25%$13.71M
Rosalind advisors1.78M6.53%$10.86M
Blackrock funding, inc. /de1.23M4.48%$7.75M
Blackrock1.19M4.39%$7.25M
Vanguard group969.75K3.54%$6.13M
Harbert fund advisors466.87K1.71%$2.95M
State street339.71K1.24%$2.15M
Geode capital management303.09K1.11%$1.92M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sonic gp2.41M33.54%$15.21M
Solas capital management2.25M7.71%$13.71M
Lion point capital, lp195.70K7.60%$1.19M
Rosalind advisors1.78M5.28%$10.86M
Harbert fund advisors466.87K1.53%$2.95M
Southpoint capital advisors lp4.08M0.60%$25.77M
Dg capital management84.21K0.18%$512.86K
Hartford financial management49.85K0.06%$315.04K
Sherbrooke park advisers21.69K0.04%$137.07K
Gendell jeffrey l199.28K0.04%$1.26M

Top Buyers

HolderShares% AssetsChange
Rosalind advisors1.78M5.28%522.97K
Blackrock1.19M0.00%259.78K
Morgan stanley102.08K-28.00K
Goldman sachs group71.20K0.00%17.44K
Metlife investment management15.68K0.00%15.68K

Top Sellers

HolderShares% AssetsChange
Dg capital management84.21K0.18%-1.03M
Aigh capital management---570.33K
Essex investment management---144.22K
Renaissance---139.90K
Vanguard group969.75K0.00%-78.14K

New Positions

HolderShares% AssetsChangeValue
Susquehanna group, llp12.43K-12.43K$78.57K
Intech investment management10.99K0.00%10.99K$69.44K
Eversource wealth advisors692.000.00%692.00$4.37K
Private wealth management group247.000.00%247.00$1.56K
Smartleaf asset management110.000.00%110.00$677.00

Sold Out

HolderChange
Newedge advisors-1.00
Nelson, van denburg & campbell wealth management group-3.00
Capital performance advisors llp-5.00
Toronto dominion bank-25.00
Citadel advisors-100.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20255-92.19%4,328,394-73.03%150.46%2-94.87%1-92.31%
Dec 31, 202431-50.00%4,180,599-72.00%150.51%23-30.30%4-73.33%
Sep 30, 202462-14,931,2843.97%541.93%33-19.51%1536.36%
Jun 30, 202462-7.46%14,360,529-0.88%531.82%4113.89%11-42.11%
Mar 31, 20246715.52%14,487,913-3.48%531.68%3624.14%1935.71%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF882.05K3.20%5.84K
Vanguard Total Stock Mkt Idx Inv793.42K2.87%-
iShares Russell 2000 ETF585.22K2.12%288.00
Fidelity Small Cap Index237.00K0.86%-
iShares Russell 2000 Value ETF156.60K0.57%-
State St Russell Sm/Mid Cp® Indx SL Cl I122.70K0.44%-
State St Russell Sm/Mid Cp® Indx NL Cl C122.70K0.44%-
Vanguard Russell 2000 ETF120.78K0.44%10.78K
State St Russell Sm Cap® Indx SL Cl I69.00K0.25%-
Schwab Small Cap Index61.15K0.22%-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 05, 2025Raykov Rosty-Sell$77.80K
May 19, 2025Hackman Jeffrey S. Chief Executive OfficerBuy$97.62K
May 16, 2025Hackman Jeffrey S. Chief Executive OfficerBuy$6.99K
May 16, 2025Raykov Rosty-Sell$113.00K
May 05, 2025Raykov Rosty-Sell$63.10K

Insider Transactions Trends


DateBuySell
2025 Q3--
2024 Q4-1
2024 Q3-4
2024 Q2218
2024 Q1-5

FENC Ownership FAQ


Who Owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals shareholders are primarily institutional investors at 15.86%, followed by 16.11% insiders and 68.03% retail investors. The average institutional ownership in Fennec Pharmaceuticals's industry, Biotech Stocks , is 63.96%, which Fennec Pharmaceuticals falls below.

Who owns the most shares of Fennec Pharmaceuticals?

Fennec Pharmaceuticals’s largest shareholders are Southpoint capital advisors lp (4.08M shares, 14.90%), Sonic gp (2.41M shares, 8.80%), and Solas capital management (2.25M shares, 8.25%). Together, they hold 31.94% of Fennec Pharmaceuticals’s total shares outstanding.

Does Blackrock own Fennec Pharmaceuticals?

Yes, BlackRock owns 4.39% of Fennec Pharmaceuticals, totaling 1.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.25M$. In the last quarter, BlackRock increased its holdings by 259.78K shares, a 28.01% change.

Who is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sonic gp is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 33.54% of its assets in 2.41M Fennec Pharmaceuticals shares, valued at 15.21M$.

Who is the top mutual fund holder of Fennec Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Fennec Pharmaceuticals shares, with 3.20% of its total shares outstanding invested in 882.05K Fennec Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools